Deutsche Bank Bullish On Biogen: New Data Doesn't Change Probability Of Success For Alzheimer's

By: via Benzinga
In a report issued Wednesday, Deutsche Bank analysts Robyn Karnauskas, Mohit Bansal and Evan Seigerman maintained a Buy rating and ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.